Literature DB >> 25183287

Effects on somatosensory and motor evoked potentials of senile patients using different doses of dexmedetomidine during spine surgery.

Z Chen1, S Lin2, W Shao1.   

Abstract

OBJECTIVE: The aim of this study was to evaluate the effects of different doses of dexmedetomidine (Dex) compounded propofol and fentanyl on intraoperative somatosensory evoked potential (SEP) and motor evoked potential (MEP) monitoring on senile patients.
METHODS: Forty-five patients undergoing elective spinal surgery were randomly divided into three groups: group C, group D1 (Dex, 0.3 μg kg(-1) h(-1)), and group D2 (Dex, 0.8 μg kg(-1) h(-1)). Anesthesia administration: midazolam, propofol, fentanyl, and cisatracurium. Anesthesia maintenance: propofol and fentanyl. No muscle relaxant was used throughout the operation. When muscle relaxation was T 4/T 1 > 75%, SEPs and MEPs were monitored for the baseline. In group D1, Dex (0.3 μg/kg, loading dose) was administered, followed by a 0.3 μg kg(-1) h(-1) infusion of said drug until the end of surgery. In group D2, Dex (0.8 μg/kg, loading dose) was injected, followed by a 0.8 μg kg(-1) h(-1) infusion of said drug.
RESULTS: Compared with group C, no significant difference was observed in the amplitude and latency of SEP (P15-N20) waves in groups D1 and D2 (P > 0.05). In groups C and D1, the MEP waveform did not disappear at every stage. In group D2, three patients lost the MEP waveform after the Dex loading dose, while four patients lost it during the Dex infusion stage. A significant difference was observed between groups C and D1. The median time to recover the MEP waveform was 47 min.
CONCLUSIONS: Dex did not affect SEPs of senile patients, but inhibited MEPs when larger doses were administered.

Entities:  

Keywords:  Anesthesia; Evoked potentials; General; Intravenous; Medetomidine; Propofol; Senile

Mesh:

Substances:

Year:  2014        PMID: 25183287     DOI: 10.1007/s11845-014-1178-0

Source DB:  PubMed          Journal:  Ir J Med Sci        ISSN: 0021-1265            Impact factor:   1.568


  20 in total

Review 1.  Anesthesia for intraoperative neurophysiologic monitoring of the spinal cord.

Authors:  Tod B Sloan; Eric J Heyer
Journal:  J Clin Neurophysiol       Date:  2002-10       Impact factor: 2.177

Review 2.  Does depth of anesthesia monitoring improve postoperative outcomes?

Authors:  Terri G Monk; B Craig Weldon
Journal:  Curr Opin Anaesthesiol       Date:  2011-12       Impact factor: 2.706

3.  Guideline 9A: guidelines on evoked potentials.

Authors: 
Journal:  Am J Electroneurodiagnostic Technol       Date:  2006-09

4.  Guideline 9D: guidelines on short-latency somatosensory evoked potentials.

Authors: 
Journal:  Am J Electroneurodiagnostic Technol       Date:  2006-09

5.  Differential rates of false-positive findings in transcranial electric motor evoked potential monitoring when using inhalational anesthesia versus total intravenous anesthesia during spine surgeries.

Authors:  Arvydas A Tamkus; Kent S Rice; Howard L Kim
Journal:  Spine J       Date:  2013-10-25       Impact factor: 4.166

6.  Susceptibility of transcranial electric motor-evoked potentials to varying targeted blood levels of dexmedetomidine during spine surgery.

Authors:  Mohamed Mahmoud; Senthilkumar Sadhasivam; Shelia Salisbury; Todd G Nick; Beverly Schnell; Anthony K Sestokas; Cheryl Wiggins; Paul Samuels; Thomas Kabalin; John McAuliffe
Journal:  Anesthesiology       Date:  2010-06       Impact factor: 7.892

7.  Pattern-specific changes and discordant prognostic values of individual leg-muscle motor evoked potentials during spinal surgery.

Authors:  Sung-Min Kim; Hyeran Yang; Soon-Bu Park; Suk Geun Han; Kun-Woo Park; Sang Hoon Yoon; Seung-Jae Hyun; Hyun-Jib Kim; Kyung Seok Park; Kwang-Woo Lee
Journal:  Clin Neurophysiol       Date:  2012-01-09       Impact factor: 3.708

8.  Neurophysiological detection of impending spinal cord injury during scoliosis surgery.

Authors:  Daniel M Schwartz; Joshua D Auerbach; John P Dormans; John Flynn; Denis S Drummond; J Andrew Bowe; Samuel Laufer; Suken A Shah; J Richard Bowen; Peter D Pizzutillo; Kristofer J Jones; Denis S Drummond
Journal:  J Bone Joint Surg Am       Date:  2007-11       Impact factor: 5.284

9.  Motor and somatosensory evoked potentials are well maintained in patients given dexmedetomidine during spine surgery.

Authors:  Endrit Bala; Daniel I Sessler; Dileep R Nair; Robert McLain; Jarrod E Dalton; Ehab Farag
Journal:  Anesthesiology       Date:  2008-09       Impact factor: 7.892

10.  Evaluation of the depth of sedation in an intensive care unit based on the photo motor reflex variations measured by video pupillometry.

Authors:  Ouri Rouche; Aurore Wolak-Thierry; Quentin Destoop; Lucas Milloncourt; Thierry Floch; Pascal Raclot; Damien Jolly; Joël Cousson
Journal:  Ann Intensive Care       Date:  2013-02-22       Impact factor: 6.925

View more
  4 in total

1.  Evaluation of the Effect of Continuous Infusion of Dexmedetomidine or a Subanesthetic Dose Ketamine on Transcranial Electrical Motor Evoked Potentials in Adult Patients Undergoing Elective Spine Surgery under Total Intravenous Anesthesia: A Randomized Controlled Exploratory Study.

Authors:  Roshan Andleeb; Sanjay Agrawal; Priyanka Gupta
Journal:  Asian Spine J       Date:  2021-08-20

2.  Dexmedetomidine as a sedative and analgesic adjuvant in spine surgery: a systematic review and meta-analysis of randomized controlled trials.

Authors:  Georgia G Tsaousi; Chryssa Pourzitaki; Simone Aloisio; Federico Bilotta
Journal:  Eur J Clin Pharmacol       Date:  2018-07-14       Impact factor: 2.953

Review 3.  Recent Advances in the Clinical Value and Potential of Dexmedetomidine.

Authors:  Xiaotian Liu; Yueqin Li; Li Kang; Qian Wang
Journal:  J Inflamm Res       Date:  2021-12-30

4.  A Loading Dose of Dexmedetomidine With Constant Infusion Inhibits Intraoperative Neuromonitoring During Thoracic Spinal Decompression Surgery: A Randomized Prospective Study.

Authors:  Tun Liu; Yue Qin; Huaguang Qi; Zhenguo Luo; Liang Yan; Pengfei Yu; Buhuai Dong; Songchuan Zhao; Xucai Wu; Zhen Chang; Zhian Liu; Xuemei Liu; Tao Yuan; Houkun Li; Li Xiao; Gang Wang
Journal:  Front Pharmacol       Date:  2022-03-07       Impact factor: 5.810

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.